Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Influenza Vaccine Effectiveness Against Influenza A(H3N2)-Related Illness in the United States During the 2021–2022 Influenza Season
Ashley M Price, Brendan Flannery, H. Keipp Talbot, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 8, pp. 1358-1363
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Vaccine effectiveness estimates from an early-season influenza A(H3N2) epidemic, including unique genetic diversity with reassortment, Canada, 2022/23
Danuta M. Skowronski, Erica Chuang, Suzana Sabaiduc, et al.
Eurosurveillance (2023) Vol. 28, Iss. 5
Open Access | Times Cited: 36
Bias in vaccine effectiveness studies of clinically severe outcomes that are measured with low specificity: the example of COVID-19-related hospitalisation
Christian Holm Hansen
Eurosurveillance (2024) Vol. 29, Iss. 7
Open Access | Times Cited: 9
Advances in Adjuvanted Influenza Vaccines
Shintaro Shichinohe, Tokiko Watanabe
Vaccines (2023) Vol. 11, Iss. 8, pp. 1391-1391
Open Access | Times Cited: 15
Recommendations for Prevention and Control of Influenza in Children, 2023–2024
Sean T. O’Leary, James D. Campbell, Monica I. Ardura, et al.
PEDIATRICS (2023) Vol. 152, Iss. 4
Closed Access | Times Cited: 15
Interim Estimates of 2023–2024 Seasonal Influenza Vaccine Effectiveness Among Adults in Korea
Yu Jung Choi, Jang Wook Sohn, Won Suk Choi, et al.
Journal of Korean Medical Science (2024) Vol. 39, Iss. 15
Open Access | Times Cited: 5
Vaccine effectiveness against influenza B/Victoria-associated medically attended influenza-like illness: Beijing, China, 2021-2022 influenza season
Chunna Ma, Ying Sun, Li Zhang, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
A single dose of inactivated influenza virus vaccine expressing COBRA hemagglutinin elicits broadly-reactive and long-lasting protection
Hua Shi, Xiaojian Zhang, Ted M. Ross
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0308680-e0308680
Open Access
Real-world effectiveness of influenza vaccination in preventing influenza and influenza-like illness in children
Vera Rigamonti, Vittorio Torri, Shaun K. Morris, et al.
Vaccine (2025) Vol. 53, pp. 126946-126946
Open Access
Vaccine Effectiveness Against Influenza-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2021–2022 Season, VISION Network
Mark W. Tenforde, Zachary A. Weber, Malini B. DeSilva, et al.
The Journal of Infectious Diseases (2023) Vol. 228, Iss. 2, pp. 185-195
Open Access | Times Cited: 14
Seasonal Influenza Vaccine Effectiveness in Persons Aged 15–64 Years: A Systematic Review and Meta-Analysis
João Paulo Martins, Marlene Santos, André Miguel Martins, et al.
Vaccines (2023) Vol. 11, Iss. 8, pp. 1322-1322
Open Access | Times Cited: 12
Influenza in Children and Adolescents: Epidemiology, Management, and Prevention
Ryan M. Wolf, James W. Antoon
Pediatrics in Review (2023) Vol. 44, Iss. 11, pp. 605-617
Closed Access | Times Cited: 10
Evolution of Influenza A(H3N2) Viruses in 2 Consecutive Seasons of Genomic Surveillance, 2021–2023
Amary Fall, Lijie Han, Madeline Yunker, et al.
Open Forum Infectious Diseases (2023) Vol. 10, Iss. 12
Open Access | Times Cited: 10
Influenza vaccine effectiveness in preventing hospital encounters for laboratory-confirmed infection among Italian adults, 2022/23 season
Alexander Domnich, Andrea Orsi, Matilde Ogliastro, et al.
Vaccine (2023) Vol. 41, Iss. 33, pp. 4861-4866
Open Access | Times Cited: 9
Low prevalence of influenza viruses and predominance of A(H3N2) virus with respect to SARS‐CoV‐2 during the 2021–2022 season in Bulgaria
Neli Korsun, Ivelina Trifonova, Veselin Dobrinov, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 2
Open Access | Times Cited: 8
Vaccination-Associated Pathogenesis
Chih‐Peng Chang, Chia Yu, Chih-Chiang Yang, et al.
(2024)
Open Access | Times Cited: 2
Estimating epidemic trajectories of SARS-CoV-2 and influenza A virus based on wastewater monitoring and a novel machine learning algorithm
Songzhe Fu, Yixiang Zhang, Yinghui Li, et al.
The Science of The Total Environment (2024) Vol. 951, pp. 175830-175830
Closed Access | Times Cited: 2
Influenza vaccine compatibility among hospitalized patients during and after the COVID-19 pandemic
Ilana S. Fratty, Menucha Jurkowicz, Neta S. Zuckerman, et al.
Frontiers in Microbiology (2024) Vol. 14
Open Access | Times Cited: 1
Targeting H3N2 Influenza: Advancements in Treatment and Vaccine Strategies
Shriyansh Srivastava, Nandani Jayaswal, Sachin Kumar, et al.
(2024)
Open Access | Times Cited: 1
Polyanhydride nanovaccine against H3N2 influenza A virus generates mucosal resident and systemic immunity promoting protection
Christopher E. Lopez, Zeb R. Zacharias, Kathleen A. Ross, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Comparative Effectiveness of Licensed Influenza Vaccines in Preventing Influenza-related Medical Encounters and Hospitalizations in the 2022–2023 Influenza Season Among Adults ≥65 Years of Age
Jennifer H. Ku, Emily Rayens, Lina S. Sy, et al.
Clinical Infectious Diseases (2024) Vol. 79, Iss. 5, pp. 1283-1292
Open Access | Times Cited: 1
Targeting H3N2 influenza: advancements in treatment and vaccine strategies
Shriyansh Srivastava, Nandani Jayaswal, Sachin Kumar, et al.
Expert Review of Anti-infective Therapy (2024)
Closed Access | Times Cited: 1
Improving in silico prediction of influenza vaccine effectiveness by genome analysis incorporating epitope information
Lirong Cao, Jingzhi Lou, Qi Li, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
The Potential Benefits of Delaying Seasonal Influenza Vaccine Selections for the Northern Hemisphere: A Retrospective Modeling Study in the United States
Kyueun Lee, Katherine V. Williams, Janet A. Englund, et al.
The Journal of Infectious Diseases (2023) Vol. 230, Iss. 1, pp. 131-140
Closed Access | Times Cited: 2
The Seasonal Influenza Vaccine Cannot Trigger a Titer Increase Among Some Elderly Individuals
Yang Ge, Wannan Cao, Shengzhi Sun, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
FLUAV RAM-IGIP: A modified live influenza virus vaccine that enhances humoral and mucosal responses against influenza
C. Joaquín Cáceres, L. Claire Gay, Aarti Jain, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Page 1 - Next Page

Scroll to top